odronextamab
regeneron
['odronextamab', 'elm-2', 'lymphoma', 'dance', 'lymsm', 'follicular']
congress | #ash22 tae min kim, md presents data from the phase ii elm-2 trial of odronextamab in pts with r/r #fl grade 1-3a. 75% of pts achieved cr by icr. safety profile was acceptable and in line with previous studies. #lymsm #medicalcongress #hematology 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm